Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC)
Recruiting · NCT07778316 · Registry updated 2026-09-17Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 3 Trial of Tarlatamab (SC vs IV) in Extensive-Stage Small Cell Lung Cancer After Platinum Based First-line Chemotherapy (ES-SCLC) | Neoplasms by Site, Thoracic Neoplasms, bronchial neoplasm, bronchogenic carcinoma, lung disorder, lung neoplasm, neoplasm, respiratory system disorder, respiratory tract neoplasm, small cell lung carcinoma | Recruiting | Phase 3 | 2026-09-17 | NCT07778316 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Amgen | 180 |
9 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Beijing Cancer Hospital | Beijing | China | 208 |
| Beijing ChaoYang Hospital | Beijing | China | 7 |
| Cancer and Hematology Centers of Western Michigan | Grand Rapids | United States | 10 |
| Lyell McEwin Hospital | Elizabeth Vale | Australia | 20 |
| Oncology Hematology West PC | Omaha | United States | 20 |
| Shanghai Pulmonary Hospital | Shanghai | China | 31 |
| Tokyo Metropolitan Komagome Hospital | Bunkyo-ku | Japan | 8 |
| UniversitaetsSpital Zuerich | Zurich | Switzerland | 15 |
| University of Florida Health Cancer Center at Orlando Health | Orlando | United States | 1 |